Compare APRE & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APRE | DKI |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 6.2M |
| IPO Year | 2019 | 2025 |
| Metric | APRE | DKI |
|---|---|---|
| Price | $0.94 | $0.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 77.2K | ★ 129.1K |
| Earning Date | 11-12-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 26.19 |
| Revenue | $488,239.00 | ★ $10,204,329.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.01 |
| Revenue Growth | N/A | ★ 100.46 |
| 52 Week Low | $0.84 | $0.30 |
| 52 Week High | $4.65 | $15.00 |
| Indicator | APRE | DKI |
|---|---|---|
| Relative Strength Index (RSI) | 41.29 | N/A |
| Support Level | $0.91 | N/A |
| Resistance Level | $1.02 | N/A |
| Average True Range (ATR) | 0.05 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 44.44 | 0.00 |
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.